KRISTEN POLENTARUTTI: Open Payments
NPI 1679135925 · MINE HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 43 payments from 11 companies in 2025. Trend: 2023 $223 · 2024 $76 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 11 | $234 |
| ABBVIE INC. | 12 | $197 |
| QOL Medical, LLC | 4 | $81 |
| Janssen Biotech, Inc. | 4 | $63 |
| PFIZER INC. | 3 | $50 |
| Aimmune Therapeutics, Inc. | 3 | $48 |
| Intercept Pharmaceuticals, Inc. | 2 | $36 |
| Exact Sciences Corporation | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $19 |
Products named: IBSRELA, CREON, Sucraid, LINZESS, TREMFYA, ZENPEP, MAVYRET, OCALIVA.
Industry payments across NJ — which companies pay providers there.
